|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Immunize.org Pages and Handouts
Featured Resources
Notable Publications
Upcoming Events
Top Stories
CDC's Health Alert Network issues advisory to clinicians about increased respiratory virus activity. Vaccinate your patients now. On Friday, November 4, the CDC issued a Health Alert Network (HAN) Health Advisory: Increased Respiratory Virus Activity, Especially among Children, Early in the 2022–2023 Fall and Winter. Cocirculation of respiratory syncytial virus (RSV), influenza viruses, SARS-CoV-2, and others are stressing healthcare systems this fall. Influenza vaccination this season should offer protection against the predominant A(H3N2) viruses to date.
Access the complete CDC HAN Health Advisory.
Back to top
Now is the time for you, your patients, and your coworkers to be vaccinated against influenza. CDC’s surveillance systems are reporting that seasonal influenza activity across the United States continues to increase. The southeastern and south-central United States continue to report the highest levels of activity. CDC expects influenza activity to continue to increase further and spread across the United States in its seasonal epidemic pattern. CDC’s Weekly U.S. Influenza Surveillance Report, FluView, provides a valuable snapshot of influenza activity state-by-state.
CDC published Routine Vaccination Coverage—Worldwide, 2021 in the November 4 issue of MMWR. Portions of the media summary appear below. High routine childhood vaccination coverage achieved during 2015–2019 declined globally for most vaccines during 2019–2021 because of COVID-19 pandemic disruptions. . . . In 2021, the estimated global coverage with 3 doses of diphtheria-tetanus-pertussis–containing vaccine as well as the first dose of measles-containing vaccine decreased to 81%, the lowest level since 2008. Globally, 25.0 million children were unvaccinated or incompletely vaccinated in 2021, 5.9 million more than in 2019. . . . Reversing declining vaccination trends and addressing immunity gaps, as well as extending previous gains in vaccination coverage beyond prepandemic levels, requires targeted and context-specific approaches that prioritize routine vaccination as an essential health service and improve access to vaccination across the life span.
“Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses among Persons Aged >12 Years—United States, August 31, 2022–October 23, 2022” published in MMWR CDC published Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses among Persons Aged >12 Years—United States, August 31, 2022–October 23, 2022 in the November 4 issue of MMWR. Portions of the media summary appear below. CDC recommended bivalent COVID-19 booster vaccination for persons aged ≥12 years in August 2022; approximately 22.6 million bivalent booster doses were administered during August 31–October 23, 2022. . . . Early safety findings from v-safe and the Vaccine Adverse Event Reporting System for bivalent booster doses administered to persons aged ≥12 years during the first 7 weeks of vaccine availability are similar to those previously described for monovalent vaccine booster vaccines. . . . Adverse events reported after a bivalent booster dose appear consistent with those reported after a monovalent booster and are less common and less serious than health impacts associated with COVID-19 illness.
CDC revises several passages in its General Best Practice Guidelines for Immunization, an important resource for daily use
On October 28, CDC updated the list of errata/updates for its General Best Practice Guidelines for Immunization. Recent updates include:
In this week's Spotlight, we summarize resources at Immunize.org that focus on influenza vaccine. IZ Express keeps 55,000+ readers up to date on what’s new in vaccines each week; invite your colleagues to subscribe!
Encourage your co-workers to subscribe to IZ Express so they get all the news that matters to vaccinators in their own inbox each Wednesday. IZ Express, the free weekly e-newsletter produced by Immunize.org, alerts 55,000+ readers to the week’s important vaccine developments. IZ Express also features:
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Pages and Handouts
Immunize.org revised its Immunizations for Babies 1-page guide for parents. Edits were made to incorporate recommendations for COVID-19 vaccination for infants beginning at age 6 months.
Immunize.org updates “Key Vaccination Resources for Healthcare Professionals” training guide organized by experience level
Immunize.org recently updated its Key Vaccination Resources for Healthcare Professionals 5-page training guide for providers. Revisions were made to update several URLs and refine content throughout the guide.
Immunize.org adds QR codes, makes minor updates to three handouts for healthcare providers and parents
Immunize.org recently updated three handouts for healthcare workers and parents with QR codes and minor revisions. The updated handouts include:
Featured Resources
Reminder: Check your document versions with Immunize.org’s "Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools"
Immunize.org revised its four-page job aid, Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools, on October 31, to help you keep up with changes to COVID-19 vaccine guidance and resources. The checklist now reflects the October 12 expansion of the bivalent mRNA booster recommendations down to age 5 years and the recommendation for Novavax monovalent vaccine as a first booster dose for adults who have completed a primary series but cannot or will not receive an mRNA bivalent vaccine booster dose. Related Links
Back to top
Immunize.org's website www.Mass-Vaccination-Resources.org assists you in finding ideas for developing your own high-volume clinics. Mass vaccination efforts are useful for influenza and COVID-19 vaccination.
 In addition, Immunize.org's on-demand full-length webinar (1 h. 46 min.) highlighting best practices and offering practical information, Mass Vaccination Clinics: Challenges and Best Practices, can be viewed on www.Mass-Vaccination-Resources.org. The www.Mass-Vaccination-Resources.org website includes a Related Resources web page linking to three articles by Immunize.org authors that appeared in Becker’s Hospital Review. If you have a resource to suggest for the website, please send a message to [email protected]. The webinar and the website are supported by a medical education grant from Seqirus. Related Links
Order Immunize.org’s child, adult, and lifetime immunization record cards—wallet-sized, designed to last!
Immunize.org's personal immunization record cards, printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
Notable Publications
"Perspectives on Maternal Vaccination from Obstetrical Clinicians: A Qualitative Multi-site Study" published in Maternal Child Health Journal In the October 31 issue, Maternal Child Health Journal published Perspectives on Maternal Vaccination from Obstetrical Clinicians: A Qualitative Multi-site Study featuring Immunize.org's Director for Research, Sharon G. Humiston, MD, MPH, FAAP. The results and conclusions sections appear below. “Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case—New York, March 9–October 11, 2022” published in MMWR CDC published Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case—New York, March 9–October 11, 2022 on October 28 in MMWR Early Release. A portion of the summary appears below.
Journal of Infectious Diseases: The Varicella Vaccination Program in the United States: 25 Years of Saving Lives and Preventing Illness supplement publishes 14 articles on saving lives and preventing illness
In an October 21 supplement, the Journal of Infectious Diseases published 14 articles on the theme of saving lives and preventing varicella illness. An excerpt from the introductory article by Mona Marin and colleagues appears below (emphasis added). In this supplement of the Journal of Infectious Diseases, we present the United States experience with the varicella vaccination program, summarizing the successes and challenges in implementing and monitoring the program over 25 years, including establishing varicella surveillance, monitoring varicella and HZ epidemiology, monitoring vaccine coverage, safety and effectiveness, clinical and laboratory issues, and economic impact. . . . Since 1995, the United States varicella vaccination program has led to prevention of more than 91 million varicella cases, 238 000 hospitalizations, and almost 2000 deaths, with an impressive return on investment with net societal savings of more than $23 billion. It is a public health achievement made possible by the efforts of thousands of nurses, physicians, pharmacists, and public health staff who implemented this immunization program. We dedicate this supplement to them and to the memory of Dr Takahashi who bravely pioneered the development of varicella-zoster virus vaccines. Related Link
Upcoming Events
Tomorrow! Virtual: Immunize Colorado hosts webinar “Seasonal Influenza: Vaccination, Prevention, and Control in the COVID-19 Era” on November 10.
Immunize Colorado will host a webinar titled Seasonal Influenza: Vaccination, Prevention, and Control in the COVID-19 Era at 1:00 p.m. (ET) on November 10. Register for the webinar. Virtual: CHOP’s Current Issues in Vaccines for Providers webinar on December 7 features Dr. Paul Offit discussing polio; CE available
The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia (CHOP) will present a 1-hour webinar titled Is Polio Coming Back? beginning at 12:00 p.m. (ET) on December 7. Part of its Current Issues in Vaccines series, the webinar will feature Paul Offit, MD, director of the VEC. Free continuing-education credits (CME, CEU, and CPE) will be available for both the live and archived events. For more upcoming events, visit our Calendar of Events.
|
||||||||||||
|
